HIV prevention and treatment for Nigerian youth aged 15-24
Part of Infections clinical trials.
This study tests better ways to find and treat HIV in young people (ages 15-24) in Nigeria. It offers either HIV prevention medicine (PrEP) if you are HIV-negative, or HIV treatment if you are newly diagnosed with HIV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 15 and 24 years old
- You were born male (any current gender identity)
- You understand basic English, Yoruba, Hausa, Igbo, or Pidgin English
- If you are HIV-negative, you can join the prevention part. If you are HIV-positive, you can join the treatment part instead
- For the treatment part: you are starting HIV treatment for the first time at a participating clinic and plan to stay with that clinic
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a support program to help young men who have sex with men and transgender women, who are living with HIV, stay engaged in their care and achieve viral suppression (an undetectable HIV viral load). The program may include extra counseling or reminders to help keep your HIV treatment on track.
This study tests ways to help young people in Uganda prevent HIV or stay healthy if they already have HIV. It offers free prevention pills or injections and care for those living with HIV.
This study helps connect young people aged 13–24 to PrEP, a daily pill that prevents HIV. It tests whether offering PrEP in clinics or community locations makes it easier for you to get and stay on this prevention medication.
This study tests if getting HIV prevention medication (PrEP) from a trained peer in your community works as well as getting it from a clinic. It is for young people aged 15 to 24 who are sexually active and not yet using PrEP.
This study tests a program to help adolescent girls and young women at high risk of HIV take PrEP consistently. It aims to improve access and adherence to PrEP, a daily pill that prevents HIV.
This study offers different forms of HIV prevention medicine (PrEP) to young women ages 18–30 who are visiting clinics for reproductive health services like family planning or postnatal care. It aims to see which delivery method works best for you.
Hear when a new Adolescent HIV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.